
Keywords: BALF; bronchoalveolar lavage fluid; BDP; beclomethasone dipropionate; CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; FACS; fluorescence-activated cell sorting; LissRhod PE; 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissaminerhoda